Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology.

British journal of cancer·2005
Same author

Hormone replacement therapy. Current controversies.

Minerva ginecologica·2003
Same author

Practice guidelines for OC selection: update.

Dialogues in contraception·2002
Same author

Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies.

The American journal of managed care·2001
Same author

Managing the transition from oral contraceptives to hormone replacement therapy.

The American journal of managed care·2001
Same author

Introduction. The hormone continuum: accrual of women's health benefits.

American journal of obstetrics and gynecology·2001
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Related Experiment Video

Updated: Jul 2, 2026

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
05:46

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation

Published on: January 17, 2019

Oral contraceptives: an update.

R T Burkman1

  • 1Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA.

Drugs of Today (Barcelona, Spain : 1998)
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Oral contraceptives carry a persistent risk of venous thromboembolism, especially with factor V Leiden. While serious cardiovascular risks are rare, smoking and hypertension increase stroke and myocardial infarction risk in users.

More Related Videos

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
04:37

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians

Published on: May 12, 2019

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Related Experiment Videos

Last Updated: Jul 2, 2026

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
05:46

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation

Published on: January 17, 2019

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
04:37

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians

Published on: May 12, 2019

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Area of Science:

  • Reproductive Health
  • Cardiovascular Risk Assessment
  • Pharmacovigilance

Background:

  • Oral contraceptives (OCs) are widely used by reproductive-aged women globally.
  • Cardiovascular risks associated with OCs require ongoing evaluation.
  • Understanding OC side effects and compliance is crucial for effective use.

Purpose of the Study:

  • To review the cardiovascular risks associated with oral contraceptive use.
  • To examine the influence of specific progestins (gestodene, desogestrel) on venous thromboembolism risk.
  • To identify factors affecting OC compliance and successful use.

Main Methods:

  • Review of recent data on cardiovascular risk in oral contraceptive users.
  • Analysis of risk factors for venous thromboembolism, ischemic stroke, hemorrhagic stroke, myocardial infarction, and breast cancer.
  • Evaluation of factors influencing oral contraceptive adherence and effectiveness.

Main Results:

  • A persistent risk of venous thromboembolism exists for all oral contraceptive users, amplified by hemostatic disorders like factor V Leiden.
  • The impact of gestodene and desogestrel on venous thromboembolism risk remains controversial.
  • Ischemic stroke and myocardial infarction risks increase significantly with smoking and hypertension, particularly in older users.
  • Hemorrhagic stroke risk is not elevated in users without hypertension or smoking.
  • A slight increase in breast cancer risk is observed, diminishing approximately 10 years post-cessation.
  • Side effects, understanding of instructions, and timing of pill intake significantly impact successful oral contraceptive use.

Conclusions:

  • While serious cardiovascular sequelae are uncommon, improved compliance is essential for enhancing oral contraceptive efficacy.
  • Risk stratification considering factors like smoking, hypertension, and genetic predisposition is vital for safe oral contraceptive prescribing.
  • Further research may clarify the role of specific progestins in venous thromboembolism risk.